These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5623729)

  • 1. Anticancer activity of alkylating agents derived from various diamines and diols on Ehrlich Ascites carcinoma.
    Skinner WA; Scholler J
    Cancer Chemother Rep; 1967 Aug; 51(4):205-11. PubMed ID: 5623729
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of alkylating agents derived from diamines on fertility of the male mouse.
    Skinner WA; Tong HC
    Experientia; 1968 Sep; 24(9):924-5. PubMed ID: 5709039
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the mechanism of action of endoxan].
    Grunicke H; Liersch M; Holzer H; Arnold H
    Biochem Pharmacol; 1965 Nov; 14(11):1485-90. PubMed ID: 4286382
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of antineoplastic drugs on blood and tumor water-electrolyte balance in mice and rats].
    Pashinskiĭ BG
    Vopr Onkol; 1969; 15(6):65-8. PubMed ID: 5820355
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of alkylating agents on the life cycle of Ehrlich tumour cells. Autoradiographic studies.
    Palme G; Liss E
    Eur J Cancer (1965); 1965 Nov; 1(3):245-51. PubMed ID: 5874720
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenic studies of aziridine derivatives derived from various diamines.
    Jorgenson TA; Maxwell WA; Barnett M; Newell GW; Tong HC; Tokuyama F; Sutou S; Skinner WA
    Mutat Res; 1975 Apr; 31(2):115-22. PubMed ID: 1117882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differenciation of reaction mechanisms of alkylating cytostatics on Ehrlich ascites-carcinoma- and lymphatic leucemic cells].
    Kummer D; Ochs HD
    Z Krebsforsch; 1970 Mar; 73(4):315-28. PubMed ID: 4245611
    [No Abstract]   [Full Text] [Related]  

  • 10. Spectrum and selectivity of antitumor action of phenesterin.
    Degteva SA
    Fed Proc Transl Suppl; 1965; 24(6):1111-2. PubMed ID: 5215182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dichloroacetic acid derivatives with antibacterial activity. II. Dichloroacetyl derivatives and aziridine derivatives of substances with quinone structure].
    Casini G; Ferappi M; Grifantini M
    Farmaco Sci; 1966 Dec; 21(2):861-9. PubMed ID: 6010747
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of different phases in the cell cycle of ascites tumor cells under the influence of cyclophosphamide.
    Palme G; Liss E
    Antimicrob Agents Chemother (Bethesda); 1965; 5():497-502. PubMed ID: 5883465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlations between the chemical structure of Mannich bases with and without nitrogen mustard groups and their cytostatic effect on Ehrlich ascites carcinoma in albino mice].
    Werner W; Jungstand W; Gutsche W
    Arzneimittelforschung; 1970 Feb; 20(2):246-9. PubMed ID: 5467470
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis, cytostatic activity and mechanism of action of N-glycosylhalomethylazoles. A new class of alkylating agents].
    Alonso G; Alonso R; Camarasa MJ; Contreras A; García López MT; de las Heras FG; Herranz R; Sánchez-Pérez RM
    Rev Esp Oncol; 1982; 29(4):603-7. PubMed ID: 6927609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.
    Mandel HG; Connors TA; Melzack DH; Merai K
    Cancer Res; 1974 Feb; 34(2):275-80. PubMed ID: 4855748
    [No Abstract]   [Full Text] [Related]  

  • 17. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. II. A possible mechanism for potentiation of the carcinostatic activity of alkylating agents by ferrous glucuronate.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):385-402. PubMed ID: 4954025
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell hybridization study of resistance to alkylating agents.
    Phillips BJ; Ambrose EJ
    Nat New Biol; 1971 Jun; 231(22):146-7. PubMed ID: 5283016
    [No Abstract]   [Full Text] [Related]  

  • 19. New alkylating agents derived from diaziridine.
    Szantay C; Chmielewicz ZF; Bardos TJ
    J Med Chem; 1967 Jan; 10(1):101-4. PubMed ID: 6067773
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: On the number, reactivity and function of SH groups at the surface of Ehrlich ascites tumor cells.
    Löffler M; Schneider F
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1225. PubMed ID: 4477749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.